About BioModulus
- Home
- About Us
Poly (Lactic-co-Glycolic Acid) – PLGA (China)
Introduction
Poly (Lactic-co-Glycolic Acid) (PLGA) is a biodegradable and biocompatible copolymer extensively used in advanced drug delivery systems and cardiovascular medical devices. Due to its controlled degradation profile and excellent compatibility with pharmaceutical active ingredients, PLGA has become one of the most widely used polymers in the development of Drug-Eluting Balloons (DEBs), Drug-Eluting Stents (DES), microspheres, and implantable medical devices.
PLGA gradually degrades into naturally occurring lactic acid and glycolic acid, which are safely metabolized by the human body. Its customizable degradation rate allows manufacturers to achieve precise and sustained drug release, making it an ideal carrier polymer for modern interventional cardiology applications.
| Details |
|---|
| Key Features |
| Medical & Pharmaceutical Grade |
| Excellent Biocompatibility |
| Fully Biodegradable Polymer |
| Controlled Drug Release Profile |
| High Mechanical Stability |
| Excellent Film-Forming Properties |
| Suitable for Sterilization Processes |
| Consistent Molecular Weight Distribution |
| High Purity with Low Residual Monomers |
| Available in Multiple Lactic/Glycolic Ratios |
| Applications |
| Drug-Eluting Balloons (DEB) |
| Drug-Eluting Stents (DES) |
| Controlled Drug Delivery Systems |
| Bioabsorbable Medical Devices |
| Microspheres |
| Tissue Engineering |
| Pharmaceutical Research & Development |